Bioanalytical Testing Services Market
完整報告名稱與涵蓋範圍
Bioanalytical Testing Services Market Size, Share & Trends Analysis Report, By Test Type (Pharmacokinetic Testing, Immunogenicity & ADA Testing, Biomarker Testing, Bioavailability & Bioequivalence Studies, Cell-Based & Virology Assays), By Molecule Type (Small Molecules, Large Molecules & Biologics, Cell & Gene Therapy Products), By Workflow (Method Development & Optimization, Method Validation, Sample Analysis), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
Bioanalytical testing services quantify drugs, metabolites, biomarkers and anti-drug antibodies in biological matrices to support drug development from discovery through post-approval commitments. The market covers outsourced pharmacokinetic and toxicokinetic analysis, immunogenicity assessment, biomarker assays, bioavailability and bioequivalence studies, and cell-based and virology testing, performed under regulated GLP and GCP conditions by contract laboratories on behalf of drug sponsors.
Growth follows the changing composition of the development pipeline. Biologics, bispecifics, antibody drug conjugates and cell and gene therapies demand far more complex assay cascades than conventional small molecules, combining ligand-binding assays, hybrid LC-MS/MS approaches, flow cytometry and molecular methods for vector shedding and transgene expression, which lifts revenue per programme and rewards laboratories with rare technical depth. Regulatory tightening, including harmonised ICH M10 bioanalysis expectations, raises validation workloads and pushes sponsors toward accredited specialist providers rather than internal labs. Additional trends include automation and high-resolution mass spectrometry for sensitivity gains, decentralised sampling formats such as microsampling, and rising bioequivalence study volumes from generics and biosimilar filings in emerging markets.
North America hosts the deepest sponsor base and leads outsourcing spend, Europe follows with strong regulatory science capabilities, and Asia Pacific grows fastest as trial activity, generics filings and cost-competitive laboratory capacity expand in China and India. The provider landscape is fragmented, ranging from global CRO divisions to focused bioanalytical specialists, and consolidation through acquisition is a persistent theme.
The InsightAce study presents US$ revenue forecasts for all test type, molecule, workflow, end user and regional segments over 2026-2035, plus segment trend analysis, competitive landscape mapping and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Bioanalytical Testing Services Market Snapshot
Chapter 4. Global Bioanalytical Testing Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Test Type Estimates & Trend Analysis
5.1. Test Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Test Type:
5.2.1. Pharmacokinetic Testing
5.2.2. Immunogenicity & ADA Testing
5.2.3. Biomarker Testing
5.2.4. Bioavailability & Bioequivalence Studies
5.2.5. Cell-Based & Virology Assays
Chapter 6. Market Segmentation 2: By Molecule Type Estimates & Trend Analysis
6.1. Molecule Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Molecule Type:
6.2.1. Small Molecules
6.2.2. Large Molecules & Biologics
6.2.3. Cell & Gene Therapy Products
Chapter 7. Market Segmentation 3: By Workflow Estimates & Trend Analysis
7.1. Workflow & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Workflow:
7.2.1. Method Development & Optimization
7.2.2. Method Validation
7.2.3. Sample Analysis
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Contract Research Organizations
8.2.3. Academic & Government Institutes
Chapter 9. Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Labcorp Drug Development
11.2. Thermo Fisher Scientific (PPD)
11.3. ICON plc
11.4. IQVIA Holdings Inc.
11.5. Charles River Laboratories
11.6. Eurofins Scientific
11.7. SGS SA
11.8. Intertek Group plc
11.9. Altasciences
11.10. BioAgilytix Labs
11.11. Celerion Inc.
11.12. Frontage Laboratories Inc.
11.13. QPS Holdings LLC
11.14. KCAS Bio
11.15. WuXi AppTec
圖表清單 List of Tables & Figures
Table 1. Global Bioanalytical Testing Services Revenue Forecast by Test Type, 2026-2035 (US$ Mn)
Figure 1. Bioanalytical Testing Workflow Across the Drug Development Lifecycle
Table 2. Global Bioanalytical Testing Services Revenue Forecast by Molecule Type, 2026-2035 (US$ Mn)
Figure 2. Global Bioanalytical Testing Services Share by Molecule Type, 2026 & 2035
Table 3. Global Bioanalytical Testing Services Revenue Forecast by Workflow, 2026-2035 (US$ Mn)
Figure 3. Assay Complexity Comparison for Small Molecules, Biologics and Cell & Gene Therapies
Table 4. Global Bioanalytical Testing Services Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Impact of ICH M10 Harmonisation on Method Validation Demand
Table 5. North America Bioanalytical Testing Services Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Bioanalytical Testing Services Growth Opportunity Analysis
Table 6. Europe Bioanalytical Testing Services Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Ligand-Binding Assay and LC-MS/MS Platform Adoption Trends
Table 7. Asia Pacific Bioanalytical Testing Services Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Bioanalytical Testing Service Providers
Table 8. Recent Laboratory Acquisitions and Capacity Expansions in Bioanalysis
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們